Cargando…

Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers

The objective of this review was to summarize published radiomics studies dealing with infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers, and assess their quality. PubMed database was searched from January 1990 to February 2022 for articles performing radiomics on...

Descripción completa

Detalles Bibliográficos
Autores principales: Morland, David, Triumbari, Elizabeth Katherine Anna, Boldrini, Luca, Gatta, Roberto, Pizzuto, Daniele, Annunziata, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222024/
https://www.ncbi.nlm.nih.gov/pubmed/35741139
http://dx.doi.org/10.3390/diagnostics12061330
_version_ 1784732771208396800
author Morland, David
Triumbari, Elizabeth Katherine Anna
Boldrini, Luca
Gatta, Roberto
Pizzuto, Daniele
Annunziata, Salvatore
author_facet Morland, David
Triumbari, Elizabeth Katherine Anna
Boldrini, Luca
Gatta, Roberto
Pizzuto, Daniele
Annunziata, Salvatore
author_sort Morland, David
collection PubMed
description The objective of this review was to summarize published radiomics studies dealing with infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers, and assess their quality. PubMed database was searched from January 1990 to February 2022 for articles performing radiomics on PET imaging of at least 1 specified tumor type. Exclusion criteria includd: non-oncological studies; supradiaphragmatic tumors; reviews, comments, cases reports; phantom or animal studies; technical articles without a clinically oriented question; studies including <30 patients in the training cohort. The review database contained PMID, first author, year of publication, cancer type, number of patients, study design, independent validation cohort and objective. This database was completed twice by the same person; discrepant results were resolved by a third reading of the articles. A total of 162 studies met inclusion criteria; 61 (37.7%) studies included >100 patients, 13 (8.0%) were prospective and 61 (37.7%) used an independent validation set. The most represented cancers were esophagus, lymphoma, and cervical cancer (n = 24, n = 24 and n = 19 articles, respectively). Most studies focused on 18F-FDG, and prognostic and response to treatment objectives. Although radiomics and artificial intelligence are technically challenging, new contributions and guidelines help improving research quality over the years and pave the way toward personalized medicine.
format Online
Article
Text
id pubmed-9222024
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92220242022-06-24 Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers Morland, David Triumbari, Elizabeth Katherine Anna Boldrini, Luca Gatta, Roberto Pizzuto, Daniele Annunziata, Salvatore Diagnostics (Basel) Systematic Review The objective of this review was to summarize published radiomics studies dealing with infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers, and assess their quality. PubMed database was searched from January 1990 to February 2022 for articles performing radiomics on PET imaging of at least 1 specified tumor type. Exclusion criteria includd: non-oncological studies; supradiaphragmatic tumors; reviews, comments, cases reports; phantom or animal studies; technical articles without a clinically oriented question; studies including <30 patients in the training cohort. The review database contained PMID, first author, year of publication, cancer type, number of patients, study design, independent validation cohort and objective. This database was completed twice by the same person; discrepant results were resolved by a third reading of the articles. A total of 162 studies met inclusion criteria; 61 (37.7%) studies included >100 patients, 13 (8.0%) were prospective and 61 (37.7%) used an independent validation set. The most represented cancers were esophagus, lymphoma, and cervical cancer (n = 24, n = 24 and n = 19 articles, respectively). Most studies focused on 18F-FDG, and prognostic and response to treatment objectives. Although radiomics and artificial intelligence are technically challenging, new contributions and guidelines help improving research quality over the years and pave the way toward personalized medicine. MDPI 2022-05-27 /pmc/articles/PMC9222024/ /pubmed/35741139 http://dx.doi.org/10.3390/diagnostics12061330 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Morland, David
Triumbari, Elizabeth Katherine Anna
Boldrini, Luca
Gatta, Roberto
Pizzuto, Daniele
Annunziata, Salvatore
Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
title Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
title_full Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
title_fullStr Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
title_full_unstemmed Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
title_short Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
title_sort radiomics in oncological pet imaging: a systematic review—part 2, infradiaphragmatic cancers, blood malignancies, melanoma and musculoskeletal cancers
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222024/
https://www.ncbi.nlm.nih.gov/pubmed/35741139
http://dx.doi.org/10.3390/diagnostics12061330
work_keys_str_mv AT morlanddavid radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers
AT triumbarielizabethkatherineanna radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers
AT boldriniluca radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers
AT gattaroberto radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers
AT pizzutodaniele radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers
AT annunziatasalvatore radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers